Related Experiment Video
Updated: May 29, 2026
Identification of Sleeping Beauty Transposon Insertions in Solid Tumors using Linker-mediated PCR
Published on: February 1, 2013
Novel molecular and computational methods improve the accuracy of insertion site analysis in Sleeping Beauty-induced
Benjamin T Brett1, Katherine E Berquam-Vrieze, Kishore Nannapaneni
1Center for Bioinformatics and Computational Biology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa, United States of America.
Abstract:
The recent development of the Sleeping Beauty (SB) system has led to the development of novel mouse models of cancer. Unlike spontaneous models, SB causes cancer through the action of mutagenic transposons that are mobilized in the genomes of somatic cells to induce mutations in cancer genes. While previous methods have successfully identified many transposon-tagged mutations in SB-induced tumors, limitations in DNA sequencing technology have prevented a comprehensive analysis of large tumor cohorts. Here we describe a novel method for producing genetic profiles of SB-induced tumors using Illumina sequencing. This method has dramatically increased the number of transposon-induced mutations identified in each tumor sample to reveal a level of genetic complexity much greater than previously appreciated. In addition, Illumina sequencing has allowed us to more precisely determine the depth of sequencing required to obtain a reproducible signature of transposon-induced mutations within tumor samples. The use of Illumina sequencing to characterize SB-induced tumors should significantly reduce sampling error that undoubtedly occurs using previous sequencing methods. As a consequence, the improved accuracy and precision provided by this method will allow candidate cancer genes to be identified with greater confidence. Overall, this method will facilitate ongoing efforts to decipher the genetic complexity of the human cancer genome by providing more accurate comparative information from Sleeping Beauty models of cancer.
Insights
A new Illumina sequencing method enhances the analysis of Sleeping Beauty (SB) system-induced mouse cancer models. This approach identifies more transposon-induced mutations, revealing greater genetic complexity and improving cancer gene discovery.
Area of Science:
- Genomics
- Cancer Biology
- Molecular Biology
Background:
- The Sleeping Beauty (SB) transposon system generates novel mouse models for cancer research.
- Previous methods for identifying transposon-induced mutations in SB models were limited by DNA sequencing technology.
- Comprehensive analysis of large tumor cohorts was hindered, impacting the understanding of cancer genetics.
Purpose of the Study:
- To introduce a novel method for genetic profiling of SB-induced tumors using Illumina sequencing.
- To increase the number of identified transposon-induced mutations per sample.
- To reveal the genetic complexity of SB-induced tumors with greater accuracy and precision.
Main Methods:
- Utilized Illumina sequencing technology to generate genetic profiles of SB-induced tumors.
- Developed a method to comprehensively analyze transposon-induced mutations in large tumor cohorts.
- Determined optimal sequencing depth for reproducible identification of mutation signatures.
Main Results:
- Dramatically increased the number of transposon-induced mutations identified in each tumor sample.
- Revealed a higher level of genetic complexity in SB-induced tumors than previously appreciated.
- Significantly reduced sampling error compared to previous sequencing methods.
Conclusions:
- The novel Illumina sequencing method provides more accurate and precise characterization of SB-induced tumors.
- Improved identification of candidate cancer genes with greater confidence.
- Facilitates deciphering human cancer genome complexity through accurate comparative data from SB models.
More Related Videos
10:58Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
Published on: February 22, 2015
09:09Laser Capture Microdissection of Glioma Subregions for Spatial and Molecular Characterization of Intratumoral Heterogeneity, Oncostreams, and Invasion
Published on: April 12, 2020